BG
MDCO

BlackRock Group’s Medicines Co MDCO Stock Holding History

BlackRock Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.92M Buy
144,867
+46,230
+47% +$1.64M ﹤0.01% 1205
2016
Q3 		$3.72M Buy
98,637
+5,501
+6% +$207K ﹤0.01% 1253
2016
Q2 		$3.13M Buy
93,136
+6,618
+8% +$233K ﹤0.01% 1300
2016
Q1 		$2.75M Buy
86,518
+7,296
+9% +$238K ﹤0.01% 1351
2015
Q4 		$2.96M Buy
79,222
+2,506
+3% +$94.7K ﹤0.01% 1290
2015
Q3 		$2.91M Sell
76,716
-4,293
-5% -$151K ﹤0.01% 1302
2015
Q2 		$2.32M Buy
81,009
+7,562
+10% +$211K ﹤0.01% 1470
2015
Q1 		$2.06M Buy
73,447
+10,405
+17% +$292K ﹤0.01% 1471
2014
Q4 		$1.75M Buy
63,042
+3,600
+6% +$89.2K ﹤0.01% 1550
2014
Q3 		$1.32M Buy
59,442
+546
+0.9% +$13.9K ﹤0.01% 1620
2014
Q2 		$1.71M Sell
58,896
-35,900
-38% -$959K ﹤0.01% 1543
2014
Q1 		$2.69M Sell
94,796
-534
-0.6% -$17.7K ﹤0.01% 1397
2013
Q4 		$3.68M Buy
95,330
+9,447
+11% +$338K ﹤0.01% 1180
2013
Q3 		$2.88M Buy
85,883
+20,989
+32% +$669K ﹤0.01% 1290
2013
Q2 		$2M Buy
+64,894
New +$2.17M ﹤0.01% 1287

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BlackRock Group's MDCO Position: Q4 2016 in Review

BlackRock Group increased its Medicines Co (MDCO) stake by 47% in Q4 2016, buying an estimated $1.64M and bringing the position to 144,867 shares worth $4.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

BlackRock Group first reported a position in MDCO in Q2 2013 and has held it in 15 quarters since. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • BlackRock Group held 144,867 shares of Medicines Co worth $4.92M as of Q4 2016.
  • BlackRock Group bought 46,230 Medicines Co shares in Q4 2016, an estimated $1.64M.
  • Medicines Co made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1205 holding.
  • BlackRock Group first reported a position in Medicines Co in Q2 2013 and has held it in 15 quarters since.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.